Source: Statesman

Lung Therapeutics: Austin's TFF Pharmaceuticals raises $25.9M with stock offering

Austin-based TFF Pharmaceuticals said Tuesday that it has raised $25.9 million to expand its product offerings through a private stock placementThe company, which spun off from Austin-based Lung Therapeutics, was founded in 2018. It uses thin film freezing, a process designed to improve the way lung medication is delivered, to develop pharmaceutical drugs.TFF Pharmaceuticals raised the money through a private placement of stock, with is a method that involves selling [...]

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Brian Windsor's photo - CEO of Lung Therapeutics

CEO

Brian Windsor

CEO Approval Rating

90/100

Read more